Icon of the Instituts for Quality and Efficiency in Health Care

Report

Memantine in Alzheimer's disease

Status
Status: Commission completed
Project no.
A05-19C
Last updated

Report documents

  1. Executive summary of the final report

    Memantine in Alzheimer's disease

    published on
    Document type
    PDF document, 63 kB, EN, not accessible
    Download file : Executive summary of the final report (PDF document, 63 kB, EN, not accessible)

  2. Final report

    Memantine in Alzheimer's disease

    published on
    Document type
    PDF document, 1 MB, DE, not accessible
    Download file : Final report (PDF document, 1 MB, DE, not accessible)

  3. Documentation and appraisal of comments on the preliminary report

    Memantine in Alzheimer's disease

    published on
    Document type
    PDF document, 9 MB, DE, not accessible
    Download file : Documentation and appraisal of comments on the preliminary report (PDF document, 9 MB, DE, not accessible)

  4. Preliminary report

    Memantine in Alzheimer's disease

    published on
    Document type
    PDF document, 859 kB, DE, not accessible
    Download file : Preliminary report (PDF document, 859 kB, DE, not accessible)

  5. Report plan version 2.0

    Memantine in Alzheimer's disease

    published on
    Document type
    PDF document, 274 kB, DE, not accessible
    Download file : Report plan version 2.0 (PDF document, 274 kB, DE, not accessible)

  6. Documentation and appraisal of comments on the report plan version 1.0

    Memantine in Alzheimer's disease

    published on
    Document type
    PDF document, 2 MB, DE, not accessible
    Download file : Documentation and appraisal of comments on the report plan version 1.0 (PDF document, 2 MB, DE, not accessible)

  7. Amendment 2 to the report plan version 1.0

    Memantine in Alzheimer's disease

    published on
    Document type
    PDF document, 76 kB, DE, not accessible
    Download file : Amendment 2 to the report plan version 1.0 (PDF document, 76 kB, DE, not accessible)

  8. Amendment 1 to the report plan version 1.0

    Memantine in Alzheimer's disease

    published on
    Document type
    PDF document, 36 kB, DE, not accessible
    Download file : Amendment 1 to the report plan version 1.0 (PDF document, 36 kB, DE, not accessible)

  9. Report plan version 1.0

    Memantine in Alzheimer's disease

    published on
    Document type
    PDF document, 87 kB, DE, not accessible
    Download file : Report plan version 1.0 (PDF document, 87 kB, DE, not accessible)

Press releases

Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine

Change in the IQWiG final report of 2009: proof of a benefit for cognitive function; indications of a benefit for activities of daily living
Press release

Memantine in Alzheimer’s disease: reliable analyses are required

IQWiG supplements benefit assessment with previously unpublished studies
Press release

Additional information

IQWiG health information

Does memantine help?

Project details

Project no.
A05-19C
Commission
Commission awarded on 22.02.2005 by the Federal Joint Committee (GBA).
Report type
Report
Status
Commission completed
Department/Division
Drug Assessment
Topic
Head and nerves

Connected Projects

  1. Working paper

    Memantine in Alzheimer’s disease: Results of the unpublished studies IE2101 and MEM-MD-22 as well as unpublished responder analyses

    Project no.
    GA10-02
    Last updated

    Status: Commission completed

  2. Rapid report

    Responder analyses for memantine in Alzheimer´s disease - Rapid report

    Project no.
    A10-06
    Last updated

    Status: Commission completed

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page